SPINAL INVOLVEMENT IN PSORIATIC ARTHRITIS, CLINICAL AND RADIOLOGICAL STUDY

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
shaimaa frahat
Rheumatology ◽  
1991 ◽  
Vol 30 (4) ◽  
pp. 245-250 ◽  
Author(s):  
J. C. TORRE ALONSO ◽  
A. RODRIGUEZ PEREZ ◽  
J. M. ARRIBAS CASTRILLO ◽  
J. BALLINA GARCIA ◽  
J. L. RIESTRA NORIEGA ◽  
...  

2018 ◽  
Vol 45 (10) ◽  
pp. 1389-1396 ◽  
Author(s):  
Philip J. Mease ◽  
Jacqueline B. Palmer ◽  
Mei Liu ◽  
Arthur Kavanaugh ◽  
Renganayaki Pandurengan ◽  
...  

Objective.We analyzed the characteristics of patients with psoriatic arthritis (PsA) with and without axial involvement in the US-based Corrona Psoriatic Arthritis/Spondyloarthritis Registry.Methods.All patients were included who had PsA and data on axial involvement, defined as physician-reported presence of spinal involvement at enrollment, and/or radiograph or magnetic resonance imaging showing sacroiliitis. Demographics, clinical measures, patient-reported outcomes, and treatment characteristics were assessed at enrollment.Results.Of 1530 patients with PsA, 192 (12.5%) had axial involvement and 1338 (87.5%) did not. Subgroups were similar in sex, race, body mass index, disease duration, presence of dactylitis, and prevalence of most comorbidities. However, patients with axial involvement were younger and more likely to have enthesitis, a history of depression, and more frequently used biologics at enrollment. They were also more likely to have moderate/severe psoriasis (body surface area ≥ 3%, 42.5% vs 31.5%) and significantly worse disease as measured by a lower prevalence of minimal disease activity (30.1% vs 46.2%) and higher nail psoriasis scores [visual analog scale (VAS) 11.4 vs 6.5], enthesitis counts (5.1 vs 3.4), Bath Ankylosing Spondylitis Disease Activity Index (4.7 vs 3.5) scores, Bath Ankylosing Spondylitis Functional Index (3.8 vs 2.5) scores, C-reactive protein levels (4.1 vs 2.4 mg/l), and scores for physical function (Health Assessment Questionnaire, 0.9 vs 0.6), pain (VAS, 47.7 vs 36.2), and fatigue (VAS, 50.2 vs 38.6).Conclusion.Presence of axial involvement was associated with a higher likelihood of moderate/severe psoriasis, with higher disease activity and greater effect on quality of life. These findings highlight the importance of monitoring patients with PsA for signs of axial symptoms or spinal involvement.


2009 ◽  
Vol 61 (3) ◽  
pp. 386-392 ◽  
Author(s):  
José Luis FerNández-Sueiro ◽  
Alfredo Willisch ◽  
Sonia Pértega- Díaz ◽  
José Antonio Pinto Tasende ◽  
Carlos Fernández-Lopez ◽  
...  

2013 ◽  
Vol 71 (Suppl 3) ◽  
pp. 569.3-569
Author(s):  
C. Castillo-Gallego ◽  
S. Aydin ◽  
P. Emery ◽  
D. McGonagle ◽  
H. Marzo-Ortega

Rheumatology ◽  
1994 ◽  
Vol 33 (3) ◽  
pp. 255-259 ◽  
Author(s):  
T. JENKINSON ◽  
J. ARMAS ◽  
G. EVISON ◽  
M. COHEN ◽  
C. LOVELL ◽  
...  

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 759-760
Author(s):  
A. Dadalova ◽  
E. Vasilenko ◽  
R. Samigullina ◽  
V. Mazurov

Background:Axial spondyloarthritis (axSpA) is a chronic inflammatory disease is associated with a lot of comorbidities, especially the diseases of cardiovascular system. [1] These diseases not only lead to a decrease in the quality of life and disability of patients, but also to a decrease in life expectancy in comparison with the general population. [2]Objectives:The goal of study is to identify the most significant and common comorbid conditions in patients with axial spondylitis and compare their prevalence in three groups: in patients with ankylosing spondylitis, patients with psoriatic arthritis with and without spinal involvement.Methods:The study included 140 patients with a reliable diagnosis of axSpA (ASAS criteria, 2009), which were subsequently divided into three groups: patients with ankylosing spondylitis, patients with psoriatic arthritis with and without spinal involvement. In all patients comorbid conditions was evaluated.Results:The most common comorbid conditions among patients with axSpA were overweight (65%), included obesity (44%), hypertension (45%), diabetes and prediabetes (31,4%), dyslipidemia (23,6%), coronary heart disease (9,3%), diseases of the gastrointestinal tract (38,6%). Then we analyzed the prevalence of these comorbid pathologies in three groups.The characteristics of the groups are presented in Table 1.Table 1.Characteristic of the patients with axial spondyloarthritis (n=140).ResultsIndicatorankylosing spondylitispsoriatic arthritis without spinal involvementpsoriatic arthritis with spinal involvementQuantity484745Male, n (%)30 (62,5)19 (40,4)25 (55,6)Age, years (mean±SD)41,6 ± 11,053,32 ± 11,046,9 ± 10,4Disease duration, years (mean±SD)14,8 ± 9,417,1 ± 8,613,6 ± 5,9BMI, kg/m2(mean±SD)25,0 ± 4,229,2 ± 5,029,3 ± 4,0Overweight, n (%)18 (37,5)35 (74,5)38 (84,4)Included obesity, n (%)7 (14,6)19 (40,4)18 (40)Hypertension, n (%)11 (22,9)32 (68,1)21 (46,7)Diabetes and prediabetes, n (%)4 (8,3)13 (27,7)8 (17,8)Dyslipidemia, n (%)4 (8,3)13 (27,7)16 (35,6)Coronary heart disease, n (%)2 (4,2)8 (17,0)3 (6,7)Diseases of the gastrointestinal tract, n (%)19 (39,6)20 (42,6)16 (35,6)Conclusion:The prevalence of diseases of the gastrointestinal tract is approximately equal in all three groups, which is probably due to the use of non-steroidal anti-inflammatory drugs and glucocorticoids. The prevalence of the other pathology presented is significantly higher in the groups of psoriatic arthritis and does not significantly differ depending on the involvement of the spine in the pathological process.Due to the high prevalence of cardiovascular disease among patients with psoriatic arthritis, careful monitoring and timely administration of therapy is necessary.References:[1]Zhao SS, et al. Rheumatology (Oxford). 2019 Dec 22. pii: kez573. doi: 10.1093/rheumatology/kez573[2]Sinnathurai P, et al. Intern Med J. 2018 Nov;48(11):1360-1368. doi: 10.1111/imj.14046.Disclosure of Interests:None declared


Sign in / Sign up

Export Citation Format

Share Document